How It May Help: The Endocannabinoid System and Neuropathic Mechanisms
Your body’s endocannabinoid system (ECS), CB1 and CB2 receptors, native ligands such as anandamide and 2-AG, and the enzymes that regulate them, help govern nociception, inflammation, stress reactivity, mood, and sleep continuity. Low, carefully timed amounts of THC can reduce excitatory neurotransmitter release through CB1 signaling, potentially quieting spontaneous firing and allodynia. CBD, though only weakly binding these receptors, interacts with transient receptor potential channels like TRPV1 that help encode burning sensations, and it influences serotonin and glycine systems that modulate spinal gating of pain. CB2 activity on microglia and peripheral immune cells may temper inflammatory cascades that keep nerves “irritable.” In practice, these mechanisms don’t “erase” neuropathy but can raise the threshold at which flares ignite, shorten their duration, and improve sleep, an amplifier that often makes pain feel worse than it is. The art lies in building a profile that supports daytime clarity and nighttime recovery without heavy intoxication, then validating it with consistent, real-world measurements you and your clinician can trust.
